Nefense, a leader in advanced clinical hygiene and airway health solutions, has officially launched its Hypochlorous Acid (HOCl) nasal spray line, marking a significant advancement in respiratory hygiene. The new product portfolio, announced on June 4, 2026, introduces an age-specific approach to nasal wellness, offering tailored solutions for adults, children, and infants. This launch underscores Nefense's commitment to bridging the gap between daily hygiene and overall airway health.
The flagship product, Hyponasal spray, is a gentle, clinical-grade biocleanse designed to flush irritants from the nasal passages while delivering immediate soothing relief. Unlike harsh chemicals or steroids, the formulation relies on hypochlorous acid, a substance naturally produced by the body's immune system, to provide broad-spectrum antimicrobial and anti-inflammatory action. This mechanism neutralizes bacteria and viruses, helps prevent upper respiratory infections, and combats seasonal allergies, making it a versatile tool for maintaining respiratory wellness.
Nefense's new line addresses a critical need for safe and effective nasal care across all age groups. Infants and children often require milder formulations, while adults may benefit from stronger yet gentle options. By offering age-specific products, Nefense ensures that each demographic receives optimal care without compromising safety. The company collaborated with doctors and ENT specialists to develop these solutions, emphasizing evidence-based design and clinical efficacy.
The launch comes at a time when respiratory health is a growing concern globally. Hypochlorous acid has gained recognition for its ability to kill pathogens without causing irritation, making it ideal for sensitive nasal tissues. Nefense's HOCl nasal spray line not only supports daily hygiene but also provides a proactive defense against upper respiratory infections, which are common in both children and adults. For allergy sufferers, the spray offers relief by flushing out allergens and reducing inflammation.
Nefense's product family already includes XyloClean, a xylitol-based nasal spray that moisturizes and rebalances nasal passages. The addition of the HOCl line strengthens the company's portfolio, offering complementary options for consumers. Clinics and practices nationwide already offer Nefense products for in-store purchase, reflecting the trust healthcare providers place in the brand.
This announcement highlights the importance of advancing airway hygiene through science-driven innovation. By providing age-specific, gentle yet effective solutions, Nefense is helping individuals breathe better and live healthier. The full announcement, including downloadable images and bios, is available here. For more information about Nefense and its products, visit the company's website or contact Sumit Verma at (608) 330-1011 or info@nefense.com. This press release was distributed by Reportable, Inc.
